Novel single‐entry point injection technique for masseter hypertrophy treatment using botulinum neurotoxin based on patient‐reported comfort

Abstract

AbstractIntroductionBotulinum neurotoxin (BoNT) injections are widely used for the treatment of masseter muscle hypertrophy in Southeast Asia. However, there remains a lack of consensus regarding the optimal injection technique. This study aimed to compare the efficacy and patient discomfort associated with single‐entry point injections versus multiple three‐point injections for masseter muscle hypertrophy treatment with BoNT.Materials and MethodsSixteen participants, comprising both male and female Korean adults aged 22–63, were enrolled in the study. On the left side of the face, single‐entry point injections were administered, followed by multidirectional injections, while on the right side, three‐point injections were given. Pain intensity during the procedure was assessed using visual analogue scale scores.ResultOur results revealed that participants experienced lower levels of pain with single‐entry point injections compared to three‐point injections (average visual analogue scores of 3.31 and 5.19, respectively).ConclusionThese findings highlight the potential benefits of single‐entry point injections in reducing patient discomfort during masseter muscle hypertrophy treatment with BoNT. We advocate for further research to validate these findings and encourage practitioners to consider single‐entry point injections as a viable option for enhancing treatment outcomes in their clinical practice.